Trends in incidence, prevalence, and survival of breast cancer in the United Kingdom from 2000 to 2021
Nicola L. Barclay,Edward Burn,Antonella Delmestri,Talita Duarte-Salles,Asieh Golozar,Wai Yi Man,Eng Hooi Tan,Ilona Tietzova,OPTIMA Consortium,James N'Dow,Wim Witjes,Emma Jane Smith,Carla Bezuidenhout,Sarah Collen,Karin Plass,Torsten Gerriet Blum,Angelika Borkowetz,Peter-Paul Willemse,Philip Cornford,Saeed Dabestani,Maurice Schlief,Juan Gómez Rivas,Anders Bjartell,Monique Roobol,Katharina Beyer,Lionne Venderbos,Sebastiaan Remmers,Daan Nieboer,Raoul Boomsma,Bertrand De Meulder,Charles Auffray,Nesrine Taibi,Ayman Hijazy,Albert Saporta,Johann Pellet,Imran Omar,Lesley Anderson,Steven MacLennan,Sara MacLennan,Valerie Speirs,Solveiga Zibaite,Moragh Boyle,Charlotte Murray,Dianne Brown,Demi McDonald,Andres Metspalu,Jaak Vilo,Raivo Kolde,Sulev Reisberg,Elena Sügis,Marek Oja,Telver Objartel,Alberto Briganti,Giorgio Gandaglia,Martina Faticoni,Greta Matteuzzi,Claude Chelala,Louise Jones,Maryam Abdollahyan,Emanuela Gadaleta,Guido Juckeland,Michael Bussmann,Daniel Kotik,Artur Yakimovich,Torsten Bauer,Jens Kollmeier,Jessica Werchan,Torsten Blum,Rebecca Graebig-Rancourt,Tobias Sjöblom,Chatarina Larsson,Arvid Widenlou Nordmark,Daniel Prieto-Alhambra,Sara Khalid,Edward Burn,Antonella Delmestri,Mahkameh Mafi,Danielle Newby,Cheryl Tan,Nikolaus Forgó,Antoni Napieralski,Martina Wimmer,Katharina Haimbuchner,Saskia Kaltenbrunner,Katja Hartl,Kseniia Guliaeva,Giuseppe Curigliano,Carmen Criscitiello,Stefania Morganti,Chiara Corti,Elena Dal Zotto,Nadia Harbeck,Julian Koch,Neal Navani,Sam Janes,Amyn Bhamani,Stephane Lejeune,Mario Campone,Jean-Sebastien Frenel,Kevin Joubel,François Bocquet,Camille Berneur,Marion Laloue,Malvina Dutot,Ludovic Jacob,Delphine Macle,Stéphanie Thauvin,Fanny Seguin,Catherine Le Manach,Philippe Lambin,Anshu Ankolekar,Talita Duarte-Salles,Laura Perez,Valérie Vaccaro,Thomy Tonia,Céline Genton,Wouter van Geffen,Ilona Tietzova,Armin Frille,Vincent Fallet,Adrien Costantini,Simone Wesselmann,Christoph Kowalski,Nora Tabea Sibert,Ellen Griesshammer,Pippa Powell,Clare Williams,Sigrid van Dorp,Nadia Honing,Javier Téllez,Sandra Garrido,Roberto Galán,Ruben Villoria,Inmaculada Perea Fernández,Paloma López de Arenosa Barbeito,Enric Bousoño Borrull,Laura Tur Giménez,Soralys Hernandez,Pablo Gonzalez Fuente,Juan Miguel Auñón García,José Carlos Barrios González,Alvaro Morandeira Galban,Andreas Kremer,Maria Quaranta,Sebastiano La Ferla,Loic Marc,Nils Christian,Christian Bauer,Mariana Pina,Sigrid Auweter,Julia Reichwald,Corinna Zur Bonsen-Thomas,Larissa Tschetsch,Francisco Pinto,Samuel Lesuffleur,Matthieu Blottière,Louise Duflot,David Vallas,Pierre-Olivier Chaudé,Marie Baumier,Daniele Cremonini,Patrizia Torremante,Florian Fromm,Verena von Scharfenberg,Karin Rosenits,Nuno Azevedo,Marcel Hartig,Waltraud Kantz,Frederic Kube,Amanda Matthews,Bhakti Arondekar,Bruno Gori,Hagen Krüger,Julia Ilinares,Keith Wilner,Lucile Serfass,Lynn McRoy,Robert Miller,Simon Bauer,Sofia Simon,Georgios Papanastasiou,Karen Godbold,Edwina Cahill,Stefan Langhammer,Anne Adams,Sebastian Boie,Florian Reis,Susan Evans Axelsson,John-Edward Butler-Ransohoff,Imke Meyer,Selmin Ulusu Saatci,Samu Kurki,Helene Ostojic,Abdelali Majdi,Santiago Villalba,Sai Jasti,Adrian Wolny,Lisa Schneider,Adrian Rousset,Ivo Cleuren,Sandra Eketorp Sylvan,Ellie Paintin,Monika Pokrzepa,Nicolas Pourbaix,Carolin Lorber,Marlene Thomas,Stefanie Morris,Joao Mouta,Martina von Meyenn,Mahesh Shivhare,Thomas Metcalfe,Camille Andre,Tobias Schulte in den Baeumen,Jason Hannon,Alan Mark Hochberg,Kartick Sukumaran,Jie Shen,Nareen Katta,Yilin Xu,Sean Turner,John Ossyra,David Dellamonica,Heather Moses,Yiduo Zhang,Christophe Dufour,Marcus Simon,Maria Teresa Campos,Hassan Naqvi,Jens Ceder,Olga Alekseeva,Burkhard Mueller,Tobias Flosdorf,Ruben Koch,Anastasia Goette,Gustaf Hedström,Per-Henrik Edqvist,Daniel Prieto-Alhambra,Danielle Newby
DOI: https://doi.org/10.1038/s41598-024-69006-1
IF: 4.6
2024-08-19
Scientific Reports
Abstract:Breast cancer is the most frequently diagnosed cancer in females globally. However, we know relatively little about trends in males. This study describes United Kingdom (UK) secular trends in breast cancer from 2000 to 2021 for both sexes. We describe a population-based cohort study using UK primary care Clinical Practice Research Datalink (CPRD) GOLD and Aurum databases. There were 5,848,436 eligible females and 5,539,681 males aged 18+ years, with ≥ one year of prior data availability in the study period. We estimated crude breast cancer incidence rates (IR), prevalence and survival probability at one-, five- and 10-years after diagnosis using the Kaplan–Meier method. Analyses were further stratified by age. Crude IR of breast cancer from 2000 to 2021 was 194.4 per 100,000 person-years for females and 1.16 for males. Crude prevalence in 2021 was 2.1% for females and 0.009% for males. Both sexes have seen around a 2.5-fold increase in prevalence across time. Incidence increased with age for both sexes, peaking in females aged 60–69 years and males 90+ . There was a drop in incidence for females aged 70–79 years. From 2003–2019, incidence increased > twofold in younger females (aged 18–29: IR 2.12 in 2003 vs. 4.58 in 2018); decreased in females aged 50–69 years; and further declined from 2015 onwards in females aged 70–89 years. Survival probability for females after one-, five-, and ten-years after diagnosis was 95.1%, 80.2%, and 68.4%, and for males 92.9%, 69.0%, and 51.3%. Survival probability at one-year increased by 2.08% points, and survival at five years increased by 5.39% from 2000–2004 to 2015–2019 for females, particularly those aged 50–70 years. For males, there were no clear time-trends for short-term and long-term survival probability. Changes in incidence of breast cancer in females largely reflect the success of screening programmes, as rates rise and fall in synchronicity with ages of eligibility for such programmes. Overall survival from breast cancer for females has improved from 2000 to 2021, again reflecting the success of screening programmes, early diagnosis, and improvements in treatments. Male breast cancer patients have worse survival outcomes compared to females, highlighting the need to develop male-specific diagnosis and treatment strategies to improve long-term survival in line with females.
multidisciplinary sciences